![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NHS |
Gene summary for NHS |
![]() |
Gene information | Species | Human | Gene symbol | NHS | Gene ID | 4810 |
Gene name | NHS actin remodeling regulator | |
Gene Alias | CTRCT40 | |
Cytomap | Xp22.2-p22.13 | |
Gene Type | protein-coding | GO ID | GO:0001654 | UniProtAcc | Q6T4R5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
4810 | NHS | CCI_1 | Human | Cervix | CC | 6.42e-04 | 5.73e-01 | 0.528 |
4810 | NHS | CCI_2 | Human | Cervix | CC | 1.68e-08 | 7.46e-01 | 0.5249 |
4810 | NHS | CCI_3 | Human | Cervix | CC | 3.40e-16 | 8.11e-01 | 0.516 |
4810 | NHS | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.17e-02 | -3.99e-01 | -0.1207 |
4810 | NHS | HTA11_696_2000001011 | Human | Colorectum | AD | 6.59e-05 | -2.93e-01 | -0.1464 |
4810 | NHS | HTA11_866_2000001011 | Human | Colorectum | AD | 3.39e-02 | -2.46e-01 | -0.1001 |
4810 | NHS | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.98e-06 | -2.88e-01 | 0.3859 |
4810 | NHS | A015-C-203 | Human | Colorectum | FAP | 1.55e-08 | -2.26e-01 | -0.1294 |
4810 | NHS | A002-C-203 | Human | Colorectum | FAP | 2.38e-05 | 5.32e-01 | 0.2786 |
4810 | NHS | A001-C-108 | Human | Colorectum | FAP | 2.26e-03 | 7.67e-02 | -0.0272 |
4810 | NHS | A002-C-205 | Human | Colorectum | FAP | 1.17e-04 | -2.10e-01 | -0.1236 |
4810 | NHS | A015-C-006 | Human | Colorectum | FAP | 3.32e-02 | -3.20e-02 | -0.0994 |
4810 | NHS | A002-C-114 | Human | Colorectum | FAP | 1.15e-03 | -2.86e-01 | -0.1561 |
4810 | NHS | A015-C-104 | Human | Colorectum | FAP | 4.16e-12 | -3.13e-01 | -0.1899 |
4810 | NHS | A001-C-014 | Human | Colorectum | FAP | 3.64e-02 | 7.85e-03 | 0.0135 |
4810 | NHS | A002-C-016 | Human | Colorectum | FAP | 1.25e-07 | -4.38e-02 | 0.0521 |
4810 | NHS | A001-C-203 | Human | Colorectum | FAP | 7.89e-03 | -8.55e-03 | -0.0481 |
4810 | NHS | A002-C-116 | Human | Colorectum | FAP | 1.19e-12 | -1.35e-01 | -0.0452 |
4810 | NHS | A018-E-020 | Human | Colorectum | FAP | 8.43e-04 | -2.62e-01 | -0.2034 |
4810 | NHS | F034 | Human | Colorectum | FAP | 4.39e-04 | -5.44e-02 | -0.0665 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0150063 | Cervix | CC | visual system development | 63/2311 | 375/18723 | 6.58e-03 | 3.65e-02 | 63 |
GO:0001654 | Cervix | CC | eye development | 62/2311 | 371/18723 | 7.83e-03 | 4.13e-02 | 62 |
GO:0048880 | Cervix | CC | sensory system development | 63/2311 | 381/18723 | 9.29e-03 | 4.66e-02 | 63 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NHS | deletion | Frame_Shift_Del | novel | c.863delC | p.Pro288GlnfsTer10 | p.P288Qfs*10 | Q6T4R5 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
NHS | deletion | Frame_Shift_Del | novel | c.2153delG | p.Ser718IlefsTer41 | p.S718Ifs*41 | Q6T4R5 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
NHS | SNV | Missense_Mutation | rs770236873 | c.2620N>A | p.Ala874Thr | p.A874T | Q6T4R5 | protein_coding | deleterious(0.02) | benign(0.035) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
NHS | SNV | Missense_Mutation | novel | c.4534N>T | p.Arg1512Cys | p.R1512C | Q6T4R5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
NHS | SNV | Missense_Mutation | c.2240N>T | p.Ser747Leu | p.S747L | Q6T4R5 | protein_coding | deleterious(0.02) | probably_damaging(0.996) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
NHS | SNV | Missense_Mutation | rs200313691 | c.902N>T | p.Pro301Leu | p.P301L | Q6T4R5 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-C5-A2LS-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
NHS | SNV | Missense_Mutation | novel | c.2547N>T | p.Lys849Asn | p.K849N | Q6T4R5 | protein_coding | tolerated(0.1) | possibly_damaging(0.756) | TCGA-C5-A901-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
NHS | SNV | Missense_Mutation | novel | c.2068N>A | p.Asp690Asn | p.D690N | Q6T4R5 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-DS-A5RQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | cisplatin | CR |
NHS | SNV | Missense_Mutation | rs764301455 | c.1279N>C | p.Glu427Gln | p.E427Q | Q6T4R5 | protein_coding | tolerated(0.15) | probably_damaging(0.997) | TCGA-EA-A439-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD |
NHS | SNV | Missense_Mutation | c.1898C>T | p.Ser633Phe | p.S633F | Q6T4R5 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-EA-A43B-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |